Related references
Note: Only part of the references are listed.A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers
Katarina Varnas et al.
CEPHALALGIA (2013)
Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain
Magdalena Nord et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
5-HT radioligands for human brain imaging with PET and SPECT
Louise M. Paterson et al.
MEDICINAL RESEARCH REVIEWS (2013)
Confirmation of fenfluramine effect on 5-HT1B receptor binding of [11C]AZ10419369 using an equilibrium approach
Sjoerd J. Finnema et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study
S. Selvaraj et al.
MOLECULAR PSYCHIATRY (2012)
Quantification of serotonin transporter availability with [11C]MADAM - A comparison between the ECAT HRRT and HR systems
Martin Schain et al.
NEUROIMAGE (2012)
Reproducibility of striatal and thalamic dopamine D2 receptor binding using [C-11]raclopride with high-resolution positron emission tomography
Kati Alakurtti et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Quantitative analysis of [C-11]AZ10419369 binding to 5-HT1B receptors in human brain
Katarina Varnas et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds
Jan D. Andersson et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Fenfluramine-Induced Serotonin Release Decreases [11C]AZ10419369 Binding to 5-HT1B-Receptors in the Primate Brain
S. J. Finnema et al.
SYNAPSE (2010)
The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression
B. M. Ruf et al.
CURRENT DRUG TARGETS (2009)
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT
Andrea Varrone et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
[11C]AZ10419369:: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET).: Characterization in the primate brain
M. Edward Pierson et al.
NEUROIMAGE (2008)
Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-C-11]WAY-100635 - considerations on the validity of cerebellum as a reference region
Jussi Hirvonen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria
Hristina Jovanovic et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2006)
Measurement of serotonin transporter binding with PET and [11C]MADAM:: A test-retest reproducibility study
Johan Lundberg et al.
SYNAPSE (2006)
Increased serotonin receptor availability in human sleep:: Evidence from an [18F]MPPF PET study in narcolepsy
C Derry et al.
NEUROIMAGE (2006)
Regional expression of 5-HT1B receptor mRNA in the human brain
K Varnäs et al.
SYNAPSE (2005)
Serotonin1B receptors:: from protein to physiological function and behavior
Y Sari
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy
SL Nicholson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2002)
Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457
Z Cselényi et al.
NEUROIMAGE (2002)
The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain
A Adell et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Autoradiographic mapping of 5-HT1B and 5-HT1D receptors in the post mortem human brain using [3H]GR 125743
K Varnäs et al.
BRAIN RESEARCH (2001)
Share Paper
